SCHEMBL26006808

SCHEMBL26006808

c1ccc(-c2cccc3cccc(-c4ccc(Nc5cccc(-c6ccc7c(c6)sc6ccccc67)c5)cc4)c23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
HPGD P15428 3/20 0.37
CYP3A4 P08684 2/20 0.37
HSD17B10 Q99714 2/20 0.37
F9 P00740 1/20 0.37
MAPT P10636 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
RAB9A P51151 1/20 0.35
IDO1 P14902 1/20 0.35
MAPK10 P53779 1/20 0.35
MAPK14 Q16539 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
AR P10275 1/20 0.35
MAPK1 P28482 1/20 0.35
ALOX5 P09917 1/20 0.34
EPHX2 P34913 1/20 0.34
SLC9A1 P19634 1/20 0.34
PTGIR P43119 1/20 0.34
HDAC1 Q13547 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26006815 0.93 PTGIR (0.39) ALDH1A1HPGDCYP3A4HSD17B10F9
SCHEMBL26557607 0.93 F9 (0.39) ALDH1A1HPGDCYP3A4HSD17B10F9
SCHEMBL26006800 0.89 PTGIR (0.43) ALDH1A1HPGDCYP3A4HSD17B10F9
SCHEMBL27383882 0.87 MAPT (0.46) ALDH1A1HPGDCYP3A4HSD17B10MAPT
SCHEMBL23821226 0.85 EPHX2 (0.39) ALDH1A1HPGDCYP3A4HSD17B10F9
SCHEMBL26006804 0.85 IDO1 (0.37) ALDH1A1HPGDCYP3A4HSD17B10F9
SCHEMBL27383568 0.85 ALDH1A1 (0.45) ALDH1A1HPGDMAPTSMN1; SMN2RAB9A
SCHEMBL29315801 0.84 SLC9A1 (0.39) ALDH1A1HPGDHSD17B10MAPTSMN1; SMN2
SCHEMBL25568460 0.84 CA12 (0.43) ALDH1A1HPGDF9MAPTSMN1; SMN2
SCHEMBL24945458 0.83 ALDH1A1 (0.49) ALDH1A1HPGDCYP3A4HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230269958-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-24 US disclosed
US-20230269958-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230269958-A1 ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME ORC3, PIEZO1, OR10J3 ALDH1A1 230/4885HPGD 4391/4885CYP3A4 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.